In addition, Rumi et al. reported 22 concomitant LPD cases in a cohort of 1915 BCR-/ABL1-negative MPN patients followed up from 1970 to 2009, with a 2.79-fold increased risk, respectively [5]. This evidence concerns the gene BCR and myeloproliferative neoplasm.